Clinical Trials Directory

Trials / Completed

CompletedNCT03669848

Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?

Status
Completed
Phase
Study type
Observational
Enrollment
1,116 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Suspicions of carbon monoxide poisoning that lead to the treatment of victims are numerous. Measurement of transcutaneous carbon monoxide saturation (SpCO) is a useful diagnostic and triage tool for victims and the toxic threshold is clearly defined for both non-smokers (SpCO\> 5%) and smokers ( SpCO\> 10%). Currently, the use of e-cigarettes is democratizing. Unfortunately, the threshold for toxic SpCO is not defined for this patient profile. The risk is treating in excess or worse than underestimating carbon monoxide poisoning in e-cigarette users who would be exposed to carbon monoxide exposure.

Conditions

Interventions

TypeNameDescription
OTHERPulse CO-oximetryMeasuring blood Carbon Monoxide levels with Pulse CO-oximetry (SpCO)

Timeline

Start date
2018-09-12
Primary completion
2018-09-23
Completion
2018-09-23
First posted
2018-09-13
Last updated
2019-11-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03669848. Inclusion in this directory is not an endorsement.